Artificial intelligence (AI) is rapidly transforming the life sciences industry, with significant advancements in various areas. These innovations bring new legal challenges related to intellectual property, data protection,...more
8/22/2023
/ Algorithms ,
Artificial Intelligence ,
Clinical Trials ,
Compliance ,
Data Protection ,
Diagnostic Tests ,
Ethics ,
Food and Drug Administration (FDA) ,
Intellectual Property Protection ,
Life Sciences ,
Medical Devices ,
Medical Research ,
Pharmaceutical Industry ,
Prescription Drugs ,
Shareholders
Decision highlights the need for applicants to focus on additional improvements to technology when drafting and prosecuting applications directed to computer-implemented diagnostics methods.
On March 25, 2021, the Federal...more